🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Hemab Therapeutics Holdings, Inc. (COAG)
NASDAQ: COAG · Real-Time Price · USD
39.29
-0.57 (-1.43%)
Nov 20, 2026, 4:00 PM EST - Market closed

COAG Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Cash & Equivalents
239.1587.9774.41
Short-Term Investments
191.0997.5113.92
Cash & Short-Term Investments
430.24185.4988.33
Cash Growth
-110.00%-
Other Receivables
1.212.631.58
Receivables
1.212.631.58
Prepaid Expenses
6.724.443.33
Total Current Assets
438.16192.5593.24
Property, Plant & Equipment
1.411.72.57
Other Long-Term Assets
3.150.530.48
Total Assets
442.71194.7896.28

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Accounts Payable
5.955.733.16
Accrued Expenses
5.323.962.47
Current Portion of Leases
0.460.690.79
Other Current Liabilities
1.20.290.27
Total Current Liabilities
12.9410.686.69
Long-Term Leases
0.50.571.1
Other Long-Term Liabilities
--0.02
Total Liabilities
13.4411.257.8

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Common Stock
0.010.130.13
Additional Paid-In Capital
687.914.922.91
Retained Earnings
-256-181.86-117.95
Comprehensive Income & Other
-2.650.18-0.37
Total Common Equity
429.27-176.64-115.27
Shareholders' Equity
429.27183.5388.47
Total Liabilities & Equity
442.71194.7896.28

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Total Debt
0.971.271.89
Net Cash (Debt)
429.27184.2286.43
Net Cash Growth
-113.13%-
Net Cash Per Share
21.68194.7391.37
Filing Date Shares Outstanding
46.730.040.95
Total Common Shares Outstanding
46.710.040.95
Working Capital
425.22181.8786.55
Book Value Per Share
9.19-4107.79-121.85
Tangible Book Value
429.27-176.64-115.27
Tangible Book Value Per Share
9.19-4107.79-121.85
Machinery
1.421.251.23
Leasehold Improvements
0.080.080.08
SEC Filings: 10-K · 10-Q